Skip to main content

Closed

COCP: Cocrystal Pharma, Inc. Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Revenue growth+0.0% / yr

Operating margin-4015.1%

ROIC-163.1%

Financially safe

Stretched

Debt / equity0.35×

Interest coverage0.0×

Current ratio2.66×

Cocrystal Pharma, Inc.

COCPNASDAQ Capital Market·USD·Closed

Cocrystal Pharma, Inc.

COCPNASDAQ·USD·Closed

$0.82

−5.50%

$0.82

−$0.05 (5.50%)

52W Range

3thpctl

Volume

0.38×avg

Mkt Cap

11.31MUSD

P/E

-1.1TTM

Div Yield

–ann

52W Range

3thpctl

Volume

0.38×avg

Market Cap

11.31MUSD

P/E Ratio

-1.1TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings